Showing results (1671-1680 of 2,315) with videos related to
Sort By:
Pageof 232
Current Opinion in Urology|May 8, 2025
Toxicities of PARP inhibitors in genitourinary cancersJános Szalontai, Tibor Szarvas, Marcin Miszczyk, et al.Current Opinion in Urology|October 9, 2025
Side effect management and procedural best practices with indwelling intravesical drug-releasing systems in the treatment of bladder cancer: recommendations from expert panelsBenjamin Pradere, Maarten Schuit, Félix Guerrero-Ramos, et al.Current Opinion in Urology|August 14, 2025
Hyperthermic intravesical chemotherapy for Bacillus Calmette-Guérin-unresponsive nonmuscle-invasive bladder cancerFélix Guerrero-Ramos, Carmen Gómez-Cañizo, Mario Hernández-Arroyo, et al.Current Opinion in Urology|September 9, 2025
Oncolytic virus therapy for nonmuscle-invasive bladder cancer: current status and future directionsHiroshi Kitamura, Naotaka NishiyamaCurrent Opinion in Urology|February 9, 2026
Applications used to minimize forgotten stents: a systematic review of the literature. Is it the dawn of a new era?Lazaros Lazarou, Lazaros Tzelves, Yuhong Yuan, et al.Current Opinion in Urology|April 24, 2025
The prognostic role of prostate MRI in prostate cancer patientsPaolo Zaurito, Armando Stabile, Francesco Montorsi, et al.Current Opinion in Urology|February 24, 2026
Navigating bladder preservation in Bacillus Calmette-Guérin-unresponsive disease: how much risk is too much?Alfredo Aliaga, Cristóbal Ávila, Mario I FernándezCurrent Opinion in Urology|March 14, 2026
Personalised medicine in urothelial carcinoma: where do we stand and what is the way to go?Amena Ahmad, Oskar Lepiarczyk, Alison J BirtleCurrent Opinion in Urology|March 6, 2024
Optimal systemic therapy in men with low-volume prostate cancerAkshat Saxena, Jack Andrews, Alan Haruo Bryce, et al.Current Opinion in Urology|February 2, 2024
Testicular cancer with small metastatic burden: optimal approach in 2024Kit L Yuen, Kshitij Pandit, Dhruv Puri, et al.Pageof 232